Product Code: TMRGL9037
Cell Expansion Market - Scope of Report
TMR's report on the global cell expansion market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global cell expansion market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global cell expansion market from 2024 to 2034.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the cell expansion market.
Market Snapshot |
Market Value in 2023 | US$ 11.6 Bn |
Market Value in 2034 | US$ 40.1 Bn |
CAGR | 12.1% |
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global cell expansion market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global cell expansion market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global cell expansion market.
The report delves into the competitive landscape of the global cell expansion market. Key players operating in the global cell expansion market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global cell expansion market profiled in this report.
Key Questions Answered in Global cell expansion Market Report:
- What is the sales/revenue generated by cell expansion across all regions during the forecast period?
- What are the opportunities in the global cell expansion market?
- What are the major drivers, restraints, opportunities, and threats in the market?
- Which regional market is set to expand at the fastest CAGR during the forecast period?
- Which segment is expected to generate the highest revenue globally in 2034?
- Which segment is projected to expand at the highest CAGR during the forecast period?
- What are the market positions of different companies operating in the global market?
Cell Expansion Market - Research Objectives and Research Approach
The comprehensive report on the global cell expansion market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global cell expansion market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global cell expansion market.
Table of Contents
1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Cell Expansion Market
4. Market Overview
- 4.1. Introduction
- 4.1.1. Product Definition
- 4.1.2. Industry Evolution/Developments
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Cell Expansion Market Analysis and Forecast, 2020-2034
5. Key Insights
- 5.1. Pipeline Analysis
- 5.2. Key Product /Brand Analysis
- 5.3. Key Mergers & Acquisitions
- 5.4. COVID-19 Pandemic Impact on Industry
6. Global Cell Expansion Market Analysis and Forecast, By Cell Type
- 6.1. Introduction & Definition
- 6.2. Key Findings/Developments
- 6.3. Market Value Forecast, By Cell Type, 2020-2034
- 6.3.1. Human Cells
- 6.3.2. Stem Cells
- 6.3.2.1. Adult Stem Cells
- 6.3.2.2. Induced Pluripotent Stem Cells
- 6.3.2.3. Embryonic Stem Cells
- 6.3.3. Differentiated Cells
- 6.3.4. Animal Cells
- 6.4. Market Attractiveness Analysis, By Cell Type
7. Global Cell Expansion Market Analysis and Forecast, by Product Type
- 7.1. Introduction & Definition
- 7.2. Key Findings/Developments
- 7.3. Market Value Forecast, by Product Type, 2020-2034
- 7.3.1. Instruments
- 7.3.1.1. Cell Expansion Supporting Equipment
- 7.3.1.2. Bioreactors
- 7.3.1.3. Automated Cell Expansion
- 7.3.2. Consumables
- 7.3.2.1. Reagents
- 7.3.2.2. Media
- 7.3.2.3. Sera
- 7.3.3. Disposables
- 7.3.3.1. Bioreactor Accessories
- 7.3.3.2. Tissue Culture Flasks
- 7.3.3.3. Others
- 7.4. Market Attractiveness Analysis, by Product Type
8. Global Cell Expansion Market Analysis and Forecast, by End-user
- 8.1. Introduction & Definition
- 8.2. Key Findings/Developments
- 8.3. Market Value Forecast, by End-user, 2020-2034
- 8.3.1. Hospitals
- 8.3.2. CMOs & CROs
- 8.3.3. Biotechnology & Pharmaceutical Companies
- 8.3.4. Academic & Research Institutes
- 8.4. Market Attractiveness Analysis, by End-user
9. Global Cell Expansion Market Analysis and Forecast, by Region
- 9.1. Key Findings
- 9.2. Market Value Forecast, by Region, 2020-2034
- 9.2.1. North America
- 9.2.2. Europe
- 9.2.3. Asia Pacific
- 9.2.4. Latin America
- 9.2.5. Middle East & Africa
- 9.3. Market Attractiveness Analysis, by Region
10. North America Cell Expansion Market Analysis and Forecast
- 10.1. Introduction
- 10.2. Key Findings
- 10.3. Market Value Forecast, By Cell Type, 2020-2034
- 10.3.1. Human Cells
- 10.3.2. Stem Cells
- 10.3.2.1. Adult Stem Cells
- 10.3.2.2. Induced Pluripotent Stem Cells
- 10.3.2.3. Embryonic Stem Cells
- 10.3.3. Differentiated Cells
- 10.3.4. Animal Cells
- 10.4. Market Value Forecast, by Product Type, 2020-2034
- 10.4.1. Instruments
- 10.4.1.1. Cell Expansion Supporting Equipment
- 10.4.1.2. Bioreactors
- 10.4.1.3. Automated Cell Expansion
- 10.4.2. Consumables
- 10.4.2.1. Reagents
- 10.4.2.2. Media
- 10.4.2.3. Sera
- 10.4.3. Disposables
- 10.4.3.1. Bioreactor Accessories
- 10.4.3.2. Tissue Culture Flasks
- 10.4.3.3. Others
- 10.5. Market Value Forecast, by End-user, 2020-2034
- 10.5.1. Hospitals
- 10.5.2. CMOs & CROs
- 10.5.3. Biotechnology & Pharmaceutical Companies
- 10.5.4. Academic & Research Institutes
- 10.6. Market Value Forecast, by Country, 2020-2034
- 10.6.1. U.S.
- 10.6.2. Canada
- 10.7. Market Attractiveness Analysis
- 10.7.1. By Cell Type
- 10.7.2. By Product Type
- 10.7.3. By End-user
- 10.7.4. By Country
11. Europe Cell Expansion Market Analysis and Forecast
- 11.1. Introduction
- 11.2. Key Findings
- 11.3. Market Value Forecast, By Cell Type, 2020-2034
- 11.3.1. Human Cells
- 11.3.2. Stem Cells
- 11.3.2.1. Adult Stem Cells
- 11.3.2.2. Induced Pluripotent Stem Cells
- 11.3.2.3. Embryonic Stem Cells
- 11.3.3. Differentiated Cells
- 11.3.4. Animal Cells
- 11.4. Market Value Forecast, by Product Type, 2020-2034
- 11.4.1. Instruments
- 11.4.1.1. Cell Expansion Supporting Equipment
- 11.4.1.2. Bioreactors
- 11.4.1.3. Automated Cell Expansion
- 11.4.2. Consumables
- 11.4.2.1. Reagents
- 11.4.2.2. Media
- 11.4.2.3. Sera
- 11.4.3. Disposables
- 11.4.3.1. Bioreactor Accessories
- 11.4.3.2. Tissue Culture Flasks
- 11.4.3.3. Others
- 11.5. Market Value Forecast, by End-user, 2020-2034
- 11.5.1. Hospitals
- 11.5.2. CMOs & CROs
- 11.5.3. Biotechnology & Pharmaceutical Companies
- 11.5.4. Academic & Research Institutes
- 11.6. Market Value Forecast, by Country/Sub-region, 2020-2034
- 11.6.1. Germany
- 11.6.2. U.K.
- 11.6.3. France
- 11.6.4. Italy
- 11.6.5. Spain
- 11.6.6. Rest of Europe
- 11.7. Market Attractiveness Analysis
- 11.7.1. By Cell Type
- 11.7.2. By Product Type
- 11.7.3. By End-user
- 11.7.4. By Country/Sub-region
12. Asia Pacific Cell Expansion Market Analysis and Forecast
- 12.1. Introduction
- 12.2. Key Findings
- 12.3. Market Value Forecast, By Cell Type, 2020-2034
- 12.3.1. Human Cells
- 12.3.2. Stem Cells
- 12.3.2.1. Adult Stem Cells
- 12.3.2.2. Induced Pluripotent Stem Cells
- 12.3.2.3. Embryonic Stem Cells
- 12.3.3. Differentiated Cells
- 12.3.4. Animal Cells
- 12.4. Market Value Forecast, by Product Type, 2020-2034
- 12.4.1. Instruments
- 12.4.1.1. Cell Expansion Supporting Equipment
- 12.4.1.2. Bioreactors
- 12.4.1.3. Automated Cell Expansion
- 12.4.2. Consumables
- 12.4.2.1. Reagents
- 12.4.2.2. Media
- 12.4.2.3. Sera
- 12.4.3. Disposables
- 12.4.3.1. Bioreactor Accessories
- 12.4.3.2. Tissue Culture Flasks
- 12.4.3.3. Others
- 12.5. Market Value Forecast, by End-user, 2020-2034
- 12.5.1. Hospitals
- 12.5.2. CMOs & CROs
- 12.5.3. Biotechnology & Pharmaceutical Companies
- 12.5.4. Academic & Research Institutes
- 12.6. Market Value Forecast, by Country/Sub-region, 2020-2034
- 12.6.1. China
- 12.6.2. Japan
- 12.6.3. India
- 12.6.4. Australia & New Zealand
- 12.6.5. Rest of Asia Pacific
- 12.7. Market Attractiveness Analysis
- 12.7.1. By Cell Type
- 12.7.2. By Product Type
- 12.7.3. By End-user
- 12.7.4. By Country/Sub-region
13. Latin America Cell Expansion Market Analysis and Forecast
- 13.1. Introduction
- 13.2. Key Findings
- 13.3. Market Value Forecast, By Cell Type, 2020-2034
- 13.3.1. Human Cells
- 13.3.2. Stem Cells
- 13.3.2.1. Adult Stem Cells
- 13.3.2.2. Induced Pluripotent Stem Cells
- 13.3.2.3. Embryonic Stem Cells
- 13.3.3. Differentiated Cells
- 13.3.4. Animal Cells
- 13.4. Market Value Forecast, by Product Type, 2020-2034
- 13.4.1. Instruments
- 13.4.1.1. Cell Expansion Supporting Equipment
- 13.4.1.2. Bioreactors
- 13.4.1.3. Automated Cell Expansion
- 13.4.2. Consumables
- 13.4.2.1. Reagents
- 13.4.2.2. Media
- 13.4.2.3. Sera
- 13.4.3. Disposables
- 13.4.3.1. Bioreactor Accessories
- 13.4.3.2. Tissue Culture Flasks
- 13.4.3.3. Others
- 13.5. Market Value Forecast, by End-user, 2020-2034
- 13.5.1. Hospitals
- 13.5.2. CMOs & CROs
- 13.5.3. Biotechnology & Pharmaceutical Companies
- 13.5.4. Academic & Research Institutes
- 13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
- 13.6.1. Brazil
- 13.6.2. Mexico
- 13.6.3. Rest of Latin America
- 13.7. Market Attractiveness Analysis
- 13.7.1. By Cell Type
- 13.7.2. By Product Type
- 13.7.3. By End-user
- 13.7.4. By Country/Sub-region
14. Middle East & Africa Cell Expansion Market Analysis and Forecast
- 14.1. Introduction
- 14.2. Key Findings
- 14.3. Market Value Forecast, By Cell Type, 2020-2034
- 14.3.1. Human Cells
- 14.3.2. Stem Cells
- 14.3.2.1. Adult Stem Cells
- 14.3.2.2. Induced Pluripotent Stem Cells
- 14.3.2.3. Embryonic Stem Cells
- 14.3.3. Differentiated Cells
- 14.3.4. Animal Cells
- 14.4. Market Value Forecast, by Product Type, 2020-2034
- 14.4.1. Instruments
- 14.4.1.1. Cell Expansion Supporting Equipment
- 14.4.1.2. Bioreactors
- 14.4.1.3. Automated Cell Expansion
- 14.4.2. Consumables
- 14.4.2.1. Reagents
- 14.4.2.2. Media
- 14.4.2.3. Sera
- 14.4.3. Disposables
- 14.4.3.1. Bioreactor Accessories
- 14.4.3.2. Tissue Culture Flasks
- 14.4.3.3. Others
- 14.5. Market Value Forecast, by End-user, 2020-2034
- 14.5.1. Hospitals
- 14.5.2. CMOs & CROs
- 14.5.3. Biotechnology & Pharmaceutical Companies
- 14.5.4. Academic & Research Institutes
- 14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
- 14.6.1. GCC Countries
- 14.6.2. South Africa
- 14.6.3. Rest of Middle East & Africa
- 14.7. Market Attractiveness Analysis
- 14.7.1. By Cell Type
- 14.7.2. By Product Type
- 14.7.3. By End-user
- 14.7.4. By Country/Sub-region
15. Competition Landscape
- 15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
- 15.2. Market Share Analysis, by Company (2023)
- 15.3. Company Profiles
- 15.3.1. CellGenix GmbH
- 15.3.1.1. Company Overview
- 15.3.1.2. Product Portfolio
- 15.3.1.3. SWOT Analysis
- 15.3.1.4. Financial Overview
- 15.3.1.5. Strategic Overview
- 15.3.2. Corning, Inc.
- 15.3.2.1. Company Overview
- 15.3.2.2. Product Portfolio
- 15.3.2.3. SWOT Analysis
- 15.3.2.4. Financial Overview
- 15.3.2.5. Strategic Overview
- 15.3.3. Eppendorf AG
- 15.3.3.1. Company Overview
- 15.3.3.2. Product Portfolio
- 15.3.3.3. SWOT Analysis
- 15.3.3.4. Financial Overview
- 15.3.3.5. Strategic Overview
- 15.3.4. HiMedia Laboratories
- 15.3.4.1. Company Overview
- 15.3.4.2. Product Portfolio
- 15.3.4.3. SWOT Analysis
- 15.3.4.4. Financial Overview
- 15.3.4.5. Strategic Overview
- 15.3.5. GE Healthcare
- 15.3.5.1. Company Overview
- 15.3.5.2. Product Portfolio
- 15.3.5.3. SWOT Analysis
- 15.3.5.4. Financial Overview
- 15.3.5.5. Strategic Overview
- 15.3.6. Danaher Corporation (Pall Corporation)
- 15.3.6.1. Company Overview
- 15.3.6.2. Product Portfolio
- 15.3.6.3. SWOT Analysis
- 15.3.6.4. Financial Overview
- 15.3.6.5. Strategic Overview
- 15.3.7. Terumo Corporation
- 15.3.7.1. Company Overview
- 15.3.7.2. Product Portfolio
- 15.3.7.3. SWOT Analysis
- 15.3.7.4. Financial Overview
- 15.3.7.5. Strategic Overview
- 15.3.8. Merck Millipore (Merck KGaA)
- 15.3.8.1. Company Overview
- 15.3.8.2. Product Portfolio
- 15.3.8.3. SWOT Analysis
- 15.3.8.4. Financial Overview
- 15.3.8.5. Strategic Overview
- 15.3.9. Miltenyi Biotec
- 15.3.9.1. Company Overview
- 15.3.9.2. Product Portfolio
- 15.3.9.3. SWOT Analysis
- 15.3.9.4. Financial Overview
- 15.3.9.5. Strategic Overview
- 15.3.10. Octane Biotech, Inc.
- 15.3.10.1. Company Overview
- 15.3.10.2. Product Portfolio
- 15.3.10.3. SWOT Analysis
- 15.3.10.4. Financial Overview
- 15.3.10.5. Strategic Overview
- 15.3.11. Thermo Fisher Scientific, Inc.
- 15.3.11.1. Company Overview
- 15.3.11.2. Product Portfolio
- 15.3.11.3. SWOT Analysis
- 15.3.11.4. Financial Overview
- 15.3.11.5. Strategic Overview
- 15.3.12. Lonza Group
- 15.3.12.1. Company Overview
- 15.3.12.2. Product Portfolio
- 15.3.12.3. SWOT Analysis
- 15.3.12.4. Financial Overview
- 15.3.12.5. Strategic Overview
- 15.3.13. STEMCELL Technologies, Inc.
- 15.3.13.1. Company Overview
- 15.3.13.2. Product Portfolio
- 15.3.13.3. SWOT Analysis
- 15.3.13.4. Financial Overview
- 15.3.13.5. Strategic Overview
- 15.3.14. Becton, Dickinson and Company
- 15.3.14.1. Company Overview
- 15.3.14.2. Product Portfolio
- 15.3.14.3. SWOT Analysis
- 15.3.14.4. Financial Overview
- 15.3.14.5. Strategic Overview
- 15.3.15. Bio-Techne (R&D Systems)
- 15.3.15.1. Company Overview
- 15.3.15.2. Product Portfolio
- 15.3.15.3. SWOT Analysis
- 15.3.15.4. Financial Overview
- 15.3.15.5. Strategic Overview
- 15.3.16. Takara Bio, Inc.
- 15.3.16.1. Company Overview
- 15.3.16.2. Product Portfolio
- 15.3.16.3. SWOT Analysis
- 15.3.16.4. Financial Overview
- 15.3.16.5. Strategic Overview
- 15.3.17. Cell Signaling Technology, Inc.
- 15.3.17.1. Company Overview
- 15.3.17.2. Product Portfolio
- 15.3.17.3. SWOT Analysis
- 15.3.17.4. Financial Overview
- 15.3.17.5. Strategic Overview
- 15.3.18. PeproTech
- 15.3.18.1. Company Overview
- 15.3.18.2. Product Portfolio
- 15.3.18.3. SWOT Analysis
- 15.3.18.4. Financial Overview
- 15.3.18.5. Strategic Overview